prefilled tirzepatide syringes Zepbound® - Pen 5787197 - Henry Schein Medical

The standard NHS pattern is a loading phase (injections on alternate days for up to two weeks), followed by maintenance

Most patients experience peak symptom intensity during the first 4 to 8 weeks of treatment, as their gut gradually adapts to the medication's presence

Lilly has signaled that detailed results will be presented at the American Diabetes Association Scientific Sessions in June 2026, with multiple additional Phase 3 readouts (TRIUMPH-2, TRIUMPH-3, and the cardiovascular outcomes trial) expected later in 2026 [1][10]

Wegovy is an injectable medication taken under the skin in the stomach area (abdomen), upper leg (thigh), or upper arm and per the instructions of a healthcare provider

Risks of Switching From Semaglutide to Tirzepatide Adverse Effects : Both medications may have commonly reported side effects which are generally gastrointestinal disturbances (nausea, vomiting, diarrhea, stomach upset) and injection-site reactions (1,2,4,5)